Article
Subtype-specific HERV-K102 envelope is a novel serum immunosuppressive biomarker and therapeutic target of cancer
2024-05-22
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Immune dysfunction is a hallmark of cancer and plays critical roles in immunotherapy resistance, but there is no serum biomarker that can be used to evaluate immune-dysfunction status of cancer patients. Here, we identified subtype-specific HERV-K102 envelope (K102-Env) with immunosuppressive activity in circulating blood as a novel serum immunosuppressive bioma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 07e67082-d0d6-5134-9f4e-bdb819f1ca58
- DOI
- 10.21203/rs.3.rs-4381830/v1
